Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MV NB 02

Next Previous
Search
Drug Profile

MV NB 02

Alternative Names: GD2-GD3 Vaccine; MV Neuro; MV-NB-02; Neuroblastoma vaccine - MabVax/MSKCC

Latest Information Update: 23 Apr 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Memorial Sloan-Kettering Cancer Center
  • Developer Memorial Sloan-Kettering Cancer Center; Y-mAbs Therapeutics
  • Class Cancer vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Neuroblastoma
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Neuroblastoma

Most Recent Events

  • 31 Dec 2023 Discontinued - Phase-II for Neuroblastoma (Combination therapy, In adolescents, In children, In the elderly, In infants, Late-stage disease, Metastatic disease, Second-line therapy or greater, In adults) in USA (SC)
  • 31 Dec 2023 Discontinued - Phase-II for Neuroblastoma (In adolescents, In children, In infants, Late-stage disease, Second-line therapy or greater) in USA (SC)
  • 08 Apr 2022 Updated efficacy and adverse events data from a phase II trial in Neuroblastoma presented at the 113th Annual Meeting of the American Association for Cancer Research (AACR-2022)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top